RAD December 2020 Virtual Conference - On Demand

Although diagnosis of atopic dermatitis is straightforward in children, its diagnosis is challenging in adults. Advances in research on AD epidemiology, burden and comorbidities have transformed the understanding of the course of AD, including risk factors, age of onset, disease severity and persistence, and health outcomes. Clinicians may not be aware of the epidemiology of AD for proper risk stratification, patient education and therapeutic decision-making. Atopic dermatitis is a heterogeneous disorder with variable severity of signs and symptoms, and impact on quality of life. Clinicians may not be able to assess AD severity accurately in order to optimize therapy.

Our virtual meeting allows clinicians to understand this disease better through the latest in research, expert faculty speakers, late-breaking research and Q&A sessions.

  • Revolutionizing Atopic Dermatitis – December 2020 Virtual Conference
  • Release date: December 17, 2020
  • Expiration date: January 16, 2021
  • Estimated time to complete activity: 13.75 hours
  • Jointly provided by Postgraduate Institute for Medicine and Foundation for Dermatology Education
  • This activity is supported by an independent educational grant from Incyte

Target Audience

This activity is intended for physicians and other healthcare providers engaged in the care of patients with atopic dermatitis.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Diagnose and assess the severity of atopic dermatitis
  • Identify the heterogeneous clinical characteristics and different phenotypes of atopic dermatitis
  • Recognize the high patient burden of atopic dermatitis
  • Use improved understanding of pathophysiology, disease course, and treatments in therapeutic decision-making for atopic dermatitis and related comorbidities
  • Use evidence-based treatment approaches for atopic dermatitis

Faculty

April Armstrong, MD

  • Consulting fees: Boehringer Ingelheim, Abbvie, Bristol-Myers Squibb, Dermavant, Eli Lilly, Leo Pharma, Modernizing Medicine, Novartis Pharmaceuticals Corp, Ortho Dermatologics, Pfizer Inc, Regeneron Pharmaceuticals, Sanofi Genzyme, Sun Pharma,
  • Fees for non-CME/CE services received directly from a commercial interest: Abbvie, Regeneron Pharmaceuticals, Sanofi Genzyme
  • Contracted research fees: Bristol-Myers Squibb, Dermavant, Dermira, Eli Lilly, Galderma, Janssen – ortho, Inc, Kyowa Hakko Kirin, Leo Pharmaceuticals, Pfizer Inc, Sanofi Genzyme, UCB Pharma

Robert Bissonette, MD

  • Salary: Innovaderm Research
  • Consulting fees: Abbvie, Arena, BI, CARA, Eli Lilly, Galderma, Incyte, Kyora Kirin, Leo Pharma, Pfizer, RAPT, Respivant, Sanofi Genzyme
  • Contracted research fees: Abbvie, Arcutis, Arena, Asana, Bellus, BI, CARA, Eli Lilly, Incyte, Pfizer, RAPT, Sanofi Genzyme
  • Ownership Interest greater than 5%: Innovaderm Research

David Cella
Ralph Seal Paffenbarger Professor
Chair of the Department of Medical Social Sciences
Northwestern University Feinberg School of Medicine
Chicago, Illinois USA

  • No COIs to report.

Brian Cheng, BA
Northwestern University, Feinberg School of Medicine
Chicago, Illinois

  • No COIs to report

Zelma C. Chiesa Fuxench, MD, MSCE, FAAD
Assistant Professor of Dermatology
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania, USA

  • Consulting fees: Sanofi/Regeneron
  • Fees for non-CME/CE services received directly from a commercial interest: Regeneron and Sanofi Genzyme, National Eczema Association
  • Contracted research fees: Leo Pharmaceuticals, Menlo Therapeutics, Vanda

Raj Chovatiya, MD, PhD
Assistant Professor of Dermatology
Northwestern University Feinberg School of Medicine

  • Consulting fees: Abbvie, Sanofi Genzyme

Emma Guttman-Yassky, MD

  • Salary: Mount Sinai
  • Consulting fees: Abbvie, Aditum Bio, Almirall, Amgen, Asana Biosciences, AstraZeneca, Boerhinger-Ingelheim, Cara Therapeutics, Celgene, Concert, DBV, Dermira, DS Biopharma, Eli Lilly, EMD Serono, Escalier, Galderma, Ichnos Sciences, Incyte Kyowa Kirin, Leo Pharma, Mitsubishi Tanabe, Pandion Therapeutics, Pfizer, RAPT, Therapeutics, Regeneron Pharmaceuticals, Inc., Sanofi, Sienna Biopharma, Target PharmaSolutions and Union Therapeutics.
  • Contracted research fees: Abbvie, Almirall, Amgen, AnaptysBio, Asana, Biosciences, Boerhinger-Ingelhiem, Celgene, Dermavant, DS, Biopharma, Eli Lilly, Galderma, Ichnos Sciences, Innovaderm, Janssen, Kiniska, Kyowa Kirin, Leo Pharma, Novan, Pfizer, Ralexar, Regeneron Pharmaceuticals, Inc., Sienna Biopharma, UCB and Union Therapeutics

Mark Lebwohl, MD

  • Salary: Mount Sinai
  • Consulting fees:  Aditum Bio, Allergan, Almirall, Arcutis, Inc., Avotres Therapeutics, BirchBioMed Inc., BMD skincare, Boehringer-Ingelheim, Bristol-Myers Squibb, Cara Therapeutics, Castle Biosciences, Corrona, Dermavant Sciences, Evelo, Evommune, Facilitate International Dermatologic Education, Foundation for Research and Education in Dermatology, Inozyme Pharma, Kyowa Kirin, LEO Pharma, Meiji Seika Pharma,  Menlo, Mitsubishi, Neuroderm, Pfizer, Promius/Dr. Reddy’s Laboratories, Serono, Theravance, and Verrica.
  • Contracted research fees: Abbvie, Amgen, Arcutis, Boehringer Ingelheim, Dermavant, Eli Lilly, Evommune, Incyte, Janssen Research & Development, LLC,  Leo Pharmaceutucals,  Ortho Dermatologics, Pfizer, and UCB, Inc.

Yael Anne Leshem, MD MCR
Department of Dermatology
Rabin Medical Center and Tel-Aviv University
Tel-Aviv Israel

  • Consulting fees: Sanofi/Regeneron, Abbvie

Joseph Merola, MD, PhD

  • Consulting fees: Sanofi/Regeneron, Abbvie, Dermavant, Eli Lilly, Novartis, Janssen, UCB, Celgene, Biogen, Pfizer and Leo Pharma

Noreen Heer Nicol, PhD, RN, FNP, NEA-BC
Associate Professor
University of Colorado, College of Nursing
Aurora, Colorado, USA

  • Consulting Fees: Lilly, Beiersdorf

Peck Y. Ong, MD, FACAAI, FAAAI  
Associate Professor of Clinical Pediatrics
Keck School of Medicine
University of Southern California
Children’s Hospital Los Angeles
Los Angeles, California, USA

  • Consulting fees: Pfizer, Abbvie
  • Contracted research: Regeneron

Amy Paller, MS, MD
Walter J. Hamlin Chair and Professor of Dermatology
Northwestern University, Feinberg School of Medicine
Chicago, Illinois, USA

  • Consulting Fees: Almirall, Amgen, Asana, Boehringer-Ingelheim, Castle Creek, Celgene, Dermavant, Dermira, Eli Lilly, Exicure, Forte, Galderma, Lenus, Leo, MEDA Corp, Meiji Seika, Novan, Novartis, Pfizer, Regeneron, Sanofi-Genzyme, and Sol Gel.
  • Other: Investigator for AbbVie, Anaptysbio, Celgene, Eli Lilly, Galderma, Incyte, Leo, Janssen, Novartis, and Regeneron

Elaine C. Siegfried, MD  
Professor of Pediatrics and Dermatology
Director, Division of Pediatric Dermatology
Saint Louis University and Cardinal Glennon Children’s Hospital
St. Louis, Missouri, USA

  • Consulting Fees: Regeneron, Sanofi, UCB, Abbvie, Verrica
  • Fees for non-CME/CE services received directly from a commercial interest: Regeneron, Sanofi, Verrica, Leo, Novan, Pfizer, Pierre Fabre
  • Contracted research fees: Verrica, Lilly, Janssen

Jonathan I. Silverberg, MD, PhD, MPH
Conference Chair, Revolutionizing Atopic Dermatitis
Professor of Dermatology
Director of Clinical Research
Director of Patch Testing
The George Washington University School of Medicine and Health Sciences
Washington, DC

  • Consulting fees: AbbVie, AnaptysBio, Arena, Asana, Boehringer Ingelheim, Celgene, Dermavant, Dermira, Eli Lilly and Company, Galderma, GlaxoSmithKline, Glenmark, Incyte, Kiniksa, LEO Pharma, Menlo, Novartis, Pfizer, Regeneron, Sanofi Genzyme.
  • Fees for non-CME/CE services received directly from a commercial interest: Regeneron and Sanofi Genzyme.
  • Contracted research fees: Galderma and GlaxoSmithKline.

Eric Simpson, MD, MCR
Professor of Dermatology, School of Medicine
Oregon Health & Science University
Portland, Oregon 

  • Consulting fees: AbbVie, Eli Lilly and Company, Galderma, Kyowa Hakko Kirin, LEO Pharma, Merck, Pfizer, Regeneron; and a consultant with honorarium for AbbVie, Eli Lilly and Company, Forte Bio, Galderma, LEO Pharma, Menlo Therapeutics, Novartis, Pfizer, Regeneron Pharmaceuticals, Sanofi Genzyme, Valeant.
  • Contracted research: AbbVie, Eli Lilly and Company, Galderma, Kyowa Hakko Kirin, LEO Pharma, Merck, Pfizer, Regeneron; and a consultant with honorarium for AbbVie, Eli Lilly and Company, Forte Bio, Galderma, LEO Pharma, Menlo Therapeutics, Novartis, Pfizer, Regeneron, Sanofi Genzyme, Valeant.

Professor Kristian Reich
Professor for Translational Research
Inflammatory Skin Diseases at the Institute for Health Services
Research in Dermatology and Nursing
University Clinic Hamburg- Eppendorf
Hamburg, Germany

  • Consulting fees: Abbvie, Affibody, Almirall, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Covagen, Forward Pharma, GlaxoSmithKline, Janssen-Cilag, Kyowa Kirin, LEO Pharma, Lilly, Medac, Merck Sharp & Dohme, Novartis, Ocean Pharma, Pfizer, Regeneron, Samsung Bioepis, Sanofi, Takeda, UCB, Valeant.
  • Fees for non-CME/CE services received directly from a commercial interest: AbbVie, Amgen, Biogen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen-Cilag, LEO Pharma, Lilly, Medac, Merck Sharp & Dohme, Novartis, Sandoz, Sanofi, UCB Pharma.
  • Contracted research fees: AbbVie, Affibody, Avillion, Biogen, Boehringer-Ingelheim, Bristol-Myers Squibb, Celgene, Centocor, Covagen, Fresenius Medical Care, Galapagos, GlaxoSmithKline, Janssen-Cilag, Kyowa Kirin, LEO Pharma, Lilly, Medac, Merck Sharp & Dohme, Novartis, Miltenyi, Ocean Pharma, Pfizer, Sun Pharma, Sanofi, Takeda, UCB Pharma, X-Biotech.

Anne Marie Singh, MD
Associate Professor, Division of Allergy, Immunology and Rheumatology Department of Pediatrics
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin

  • No COIs to report.

Prof. Dr. med. Diamant Thaçi
Full Professor and Head Comprehensive Center for Inflammation Medicine
University of Lübeck
Lubeck, Germany

  •  Consulting fees: AbbVie, Almerall, Amgen, Asana, Biogen Idec, BIOCAD, Boehringer Ingelheim, Bristol-Meyers Squibb, Celgene, DS-Biopharma, GlaxoSmithKline, Janssen Cilag, Kyowa Kirin, Leo Pharma, Eli Lilly, Novartis, Regeneron, Sandoz, Sanofi-Aventis and UCB
  • Other Grants: AbbVie, Novartis

Gil Yosipovitch, MD
University of Miami
Miami, FL

  • Consulting fees: Pfizer, Galderma, Sanofi Regeneron, Trevi, Leo, GSK, Novartis, Eli Lilly, Kiniksa Bellus
  • Contracted research: Pfizer, Sanofi Regeneron, Galderma, Kinksa, LEO, Novartis Kinksa, Sun Pharma

Phyllis C. Zee, MD, PhD
Benjamin and Virginia T. Boshes Professor in Neurology
Director, Center for Circadian and Sleep Medicine
Chief, Division of Sleep Medicine – Neurology
Director, Center for Circadian and Sleep Medicine
Northwestern University, Feinberg School of Medicine
Chicago, Illinois, USA

  • Consulting fees: Eisai, Merck, Jazz, Philips
  • Contracted research fees: Harmony Biosciences, Philips
  • Ownership Interest less than 5%: Teva

Nina Zhou
Professor for Translational Research
Inflammatory Skin Diseases at the Institute for Health Services
Research in Dermatology and Nursing
University Clinic Hamburg- Eppendorf
Hamburg, Germany

  • No COIs to report

Planners and Managers

The PIM planners and managers have nothing to disclose. The Foundation for Dermatology Education planners and managers have nothing to disclose.

Joint Accreditation Statement


In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Foundation for Dermatology Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 13.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 13.75 contact hours.

This activity is supported in part by Bausch Health, Incyte, and Pfizer.

Media

Internet

Computer Specifications

Microsoft Windows 10, 8.x, or Mac OS X v10.8 or higher with Google Chrome v50 or higher. 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Request for Credit

In order to obtain your CME/CE certificate, please follow the steps below at the conclusion of the on demand activity:

  1. Go to www.cmeuniversity.com
  2. Login or Create a New Account (will take less than 1 minute)
    1. If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
    2. After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
  3. Type in 15955 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
  4. Click on the activity title when it appears
  5. Choose the type of credit you desire
  6. Complete the online Evaluation
  7. Receive an immediate CME/CE Certificate to download and/or print for your files
Please click register below to register for the on demand program. Please note that the Registration Fee for this program is US $75.00 and you will not receive an email confirming registration until after the fee has been paid. If you have a discount code, please enter the code when registering. Once you do so and complete the required registration information, you will receive a confirmation email.